Analysis of the expression of PHTF1 and related genes in acute lymphoblastic leukemia

Cancer Cell International

Xin Du¹  Yangqiu Li²  Xiuli Wu³  Chengxin Deng¹  Minming Li¹  Lingji Zeng¹  Zesheng Lu¹  Jianyu Weng¹  Suxia Geng¹  Xin Huang¹ 

[1] Department of Haematology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, People’s Republic of China;Key Laboratory for Regenerative Medicine of Ministry of Education, Jinan University, Guangzhou, 510632, People’s Republic of China;Institute of Hematology, Medical College, Jinan University, Guangzhou, 510632, People’s Republic of China

关键词: Apoptosis;    Proliferation;    Overexpression;    ALL;    Apaf-1;    FEM1b;    BCL11B;    PHTF1;   

Others  :  1233587
DOI  :  10.1186/s12935-015-0242-9

 received in 2015-02-24, accepted in 2015-09-08,  发布年份 2015

【 摘 要 】

Background

Previous study showed that downregulated BCL11B expression in T cell acute lymphoblastic leukemia (T-ALL) cell line Molt-4 inhibited cell proliferation and induce apoptosis, which may be related to PHTF1 gene overexpression. The objective of this study was to investigate the expression of PHTF1 and related genes in ALL and further explore its function in T-ALL cell lines.

Methods

Real-time PCR was used to determine the gene expression level of PHTF1 in hematologic malignancies. The PHTF1, BCL11B, FEM1B and Apaf-1 gene expression levels and correlations were analyzed in patients with primary ALL (including T-ALL and B-ALL) and healthy individuals (HIs). Inhibition and overexpression of PHTF1 by lentiviral transduction were performed using the Molt-4 and Jurkat cell lines. Cell growth and apoptosis were measured by the Cell Counting Kit-8 assay and flow cytometry, respectively. Upon PHTF1 overexpression, the BCL11B, FEM1B and Apaf-1 gene expression levels were determined by real-time PCR.

Results

PHTF1 overexpression was found in both T-ALL (p = 0.004) and B-ALL (p < 0.001) groups compared with HIs group. A trend toward a negative correlation between the PHTF1 and BCL11B genes was detected for the T-ALL group, while positively correlated expression was found for the PHTF1 and BCL11B genes in HIs (P = 0.001). FEM1b and Apaf-1 overexpression was found in recently diagnosed ALL patients compared with HIs (p < 0.05). Positively correlated expression was found for the PHTF1, FEM1b and Apaf-1 genes in patients with ALL (p < 0.05) and HIs (p < 0.05). Direct up-regulation of PHTF1 expression inhibited the proliferation of Jurkat and Molt-4 cells and effectively induced apoptosis in Molt-4 cells. Direct inhibition of PHTF1 expression had no significant effect on the proliferation or apoptosis of Jurkat and Molt-4 cells. FEM1b and Apaf-1 overexpression, which did not obviously alter the BCL11B expression level, was detected in PHTF1-transduced T-ALL cell lines.

Conclusions

PHTF1 overexpression is responsible for regulating cell proliferation and apoptosis in T-ALL cell lines. PHTF1 may be a tumor-suppressor like gene and a therapeutic target for triggering the PHTF1-FEM1b-Apaf-1 apoptosis pathway.

【 授权许可】

   
2015 Huang et al.

【 图 表 】

Fig.1.

Fig.2.

Fig.3.

Fig.4.

Figure 2.

Fig.6.

Fig.7.

Fig.8.

【 参考文献 】

• [1]Aifantis I, Raetz E, Buonamici S. Molecular pathogenesis of T-cell leukaemia and lymphoma. Nat Rev Immunol. 2008; 8:380-390.
• [2]Pui CH, Relling MV, Downing JR. Acute lymphoblastic leukemia. N Engl J Med. 2004; 350:1535-1548.
• [3]Zheng HT, Wang X, Ma Y, Xu B, Chen S, Yang LJ, Wu XL, Przybylski GK, Huang SM, Ye TZ, Li YQ. The TCR gammadelta repertoire and relative gene expression characteristics of T-ALL cases with biclonal malignant Vdelta1 and Vdelta2 T cells. DNA Cell Biol. 2014; 33:49-56.
• [4]Gimenes-Teixeira HL, Lucena-Araujo AR, Dos Santos GA, Zanette DL, Scheucher PS, Oliveira LC, Dalmazzo LF, Silva-Junior WA, Falcao RP, Rego EM. Increased expression of miR-221 is associated with shorter overall survival in T-cell acute lymphoid leukemia. Exp Hematol Oncol. 2013; 2:10. BioMed Central Full Text
• [5]Chen S, Huang X, Zheng HT, Geng SX, Wu XL, Yang LJ, Weng JY, Du X, Li YQ. The evolution of malignant and reactive γδ+ T cell clones in a relapse T-ALL case after allogeneic stem cell transplantation. Mol Cancer. 2013; 12:73. BioMed Central Full Text
• [6]Oshiro A, Tagawa H, Ohshima K, Karube K, Uike N, Tashiro Y, Utsunomiya A, Masuda M, Takasu N, Nakamura S, Morishima Y, Seto M. Identification of subtype-specific genomic alterations in aggressive adult T-cell leukemia/lymphoma. Blood. 2006; 107:4500-4507.
• [7]Vanura K, Vrsalovic MM, Le T, Marculescu R, Kusec R, Jager U, Nadel B. V(D)J targeting mistakes occur at low frequency in acute lymphoblastic leukemia. Genes Chromosomes Cancer. 2009; 48:725-736.
• [8]Lin C, Zheng HT, Wang C, Yang LJ, Chen SH, Li B, Zhou YQ, Tan H, Li YQ. Mutations increased overexpression of Notch1 in T-cell acute lymphoblastic leukemia. Cancer Cell Int. 2012; 12:13. BioMed Central Full Text
• [9]Patel B, Kang Y, Cui K, Litt M, Riberio MS, Deng C, Salz T, Casada S, Fu X, Qiu Y, Zhao K, Huang S. Aberrant TAL1 activation is mediated by an interchromosomal interaction in human T-cell acute lymphoblastic leukemia. Leukemia. 2014; 28:349-361.
• [10]Huang X, Du X, Li YQ. The role of BCL11B in hematological malignancy. Exp Hematol Oncol. 2012; 1:22. BioMed Central Full Text
• [11]Liu P, Keller JR, Ortiz M, Tessarollo L, Rachel RA, Nakamura T, Jenkins NA, Copeland NG. Bcl11a is essential for normal lymphoid development. Nat Immunol. 2003; 4:525-532.
• [12]Przybylski GK, Dik WA, Wanzeck J, Grabarczyk P, Majunke S, Martin-Subero JI, Siebert R, Dölken G, Ludwig WD, Verhaaf B, van Dongen JJ, Schmidt CA, Langerak AW. Disruption of the BCL11B gene through inv 14 q11.2q32.31 results in the expression of BCL11B-TRDC fusion transcripts and is associated with the absence of wild-type BCL11B transcripts in T- ALL. Leukemia. 2005; 19:201-208.
• [13]Karlsson A, Nordigården A, Jönsson JI, Söderkvist P. Bcl11b mutations identified in murine lymphomas increase the proliferation rate of hematopoietic progenitor cells. BMC Cancer. 2007; 7:195. BioMed Central Full Text
• [14]Strehl S, Konig M, Spath K. Juxtaposition of the BCL11B gene to a novel region at 17q by a t (14; 17) (q32; Q21) in childhood T-Cell lymphoblastic lymphoma [abstract]. Blood. 2007; 110:101B.
• [15]Su XY, Della-Valle V, Andre-Schmutz I, Lemercier C, Radford-Weiss I, Ballerini P, Lessard M, Lafage-Pochitaloff M, Mugneret F, Berger R, Romana SP, Bernard OA, Penard-Lacronique V. HOX11L2/TLX3 is transcriptionally activated through T-cell regulatory elements downstream of BCL11B as a result of the t (5; 14) (q35; q32). Blood. 2006; 108:4198-4201.
• [16]Huang X, Chen S, Yang LJ, Chen SH, Zhou YB, Schmidt CA, Li YQ. Effects of down-regulating BCL11B expression on the proliferation, apoptosis and global gene expression profiling of Molt-4 cells [abstract]. Blood. 2009; 114:4505.
• [17]Grabarczyk P, Przybylski GK, Depke M, Völker U, Bahr J, Assmus K, Bröker BM, Walther R, Schmidt CA. Inhibition of BCL11B expression leads to apoptosis of malignant but not normal mature T cells. Oncogene. 2007; 26:3797-3810.
• [18]Huang X, Chen S, Shen Q, Chen SH, Yang LJ, Grabarczyk P, Przybylski GK, Schmidt CA, Li YQ. Down regulation of BCL11B expression inhibits proliferation and induces apoptosis in malignant T cells by BCL11B-935-siRNA. Hematology. 2011; 16:236-242.
• [19]Shen Q, Huang X, Chen S, Yang L, Shen SH, Li B, Wu X, Grabarczyk P, Przybylski GK, Schmidt CA, Li Y. BCL11B suppression does not influence CD34+ cell differentiation and proliferation. Hematology. 2012; 17(6):329-333.
• [20]Manuel A, Beaupain D, Romeo PH, Raich N. Molecular characterization of a novel gene family (PHTF) conserved from Drosophila to mammals. Genomics. 2000; 64(2):216-220.
• [21]Raich N, Mattei MG, Romeo PH, Beaupain D. PHTF, a novel atypical homeobox gene on chromosome 1p13, is evolutionarily conserved. Genomics. 1999; 59:108-109.
• [22]Oyhenart J, Benichou S, Raich N. Putative homeodomain transcription factor 1 interacts with the feminization factor homolog fem1b in male germ cells. Biol Reprod. 2005; 72:780-787.
• [23]Subauste MC, Sansom OJ, Porecha N, Raich N, Du L, Maher JF. Fem1b, a proapoptotic protein, mediates proteasome inhibitor-induced apoptosis of human colon cancer cells. Mol Carcinog. 2010; 49:105-113.
• [24]Huang X, Chen SH, Shen Q, Yang LJ, Li B, Zhong LY, Geng SX, Du X, Li YQ. Analysis of the expression pattern of the BCL11B gene and its relatives in patients with T-cell acute lymphoblastic leukemia. J Hematol Oncol. 2010; 3:44. BioMed Central Full Text
• [25]Luo XD, Tan H, Zhou YQ, Xiao TT, Wang CY, Li YQ. Notch1 signaling is involved in regulating Foxp3 expression in T-ALL. Cancer Cell Int. 2013; 13:34. BioMed Central Full Text
• [26]Bartram I, Gökbuget N, Schlee C, Heesch S, Fransecky L, Schwartz S, Stuhlmann R, Schäfer-Eckhart K, Starck M, Reichle A, Hoelzer D, Baldus CD, Neumann M. Low expression of T-cell transcription factor BCL11b predicts inferior survival in adult standard risk T-cell acute lymphoblastic leukemia Patients. J Hematol Oncol. 2014; 7:51. BioMed Central Full Text
• [27]Lyu X, Xin Y, Mi R, Ding J, Wang X et al.. Overexpression of Wilms tumor 1 gene as a negative prognostic indicator in acute myeloid leukemia. PLoS One. 2014; 9(3):e92470.
• [28]Chan SL, Tan KO, Zhang L, Yee KS, Ronca F, Chan MY, Yu VC. F1Aalpha, a death receptor-binding protein homologous to the Caenorhabditis elegans sex-determining protein, FEM-1, is a caspase substrate that mediates apoptosis. J Biol Chem. 1999; 274:32461-32468.
• [29]Subauste MC, Ventura-Holman T, Du L, Subauste JS, Chan SL, Yu VC, Maher JF. RACK1 downregulates levels of the pro-apoptotic protein Fem1b in apoptosis-resistant colon cancer cells. Cancer Biol Ther. 2009; 8(23):2297-2305.
• [30]Gu S, Zhao Y, Guo J, Xu F, Fei C, Zhang X, Xiao C, Chang C, Li X. High expression of APAF-1 elevates erythroid apoptosis in iron overload myelodysplastic syndrome. Tumour Biol. 2014; 35(3):2211-2218.
• [31]Zermati Y, Mouhamad S, Stergiou L, Besse B, Galluzzi L, Boehrer S, Pauleau AL, Rosselli F, D’Amelio M, Amendola R, Castedo M, Hengartner M, Soria JC, Cecconi F, Kroemer G. Nonapoptotic role for Apaf-1 in the DNA damage checkpoint. Mol Cell. 2007; 28(4):624-637.